Latest Research And Development News

Page 13 of 115
International Graphite has moved its graphite processing strategy from plans towards construction and joint ventures, but the FY2026 annual report shows the company remains loss-making and reliant on external funding. Collie is scheduled for building completion in Q2 2027, while the proposed European hub still requires financing and development work.
Victor Sage
Victor Sage
30 Sept 2026
BauMart Holdings returned to profit in FY2026 as revenue surged, but the result came alongside negative operating cash flow, net liabilities and an auditor-flagged material uncertainty over its ability to continue as a going concern. A post-year-end $244,463 placement provides near-term funding, while receivables collection remains critical.
Victor Sage
Victor Sage
30 Sept 2026
Pure Foods Tasmania has warned of a material uncertainty over its ability to continue as a going concern after reporting an $8.6 million FY2026 loss, negative cash and a breach of its Commonwealth Bank covenant. The company expects its existing funding facilities to fall short from approximately February 2027, with further equity funding still uncommitted.
Victor Sage
Victor Sage
30 Sept 2026
Yojee enters FY27 with 12 signed MOSAIC customer agreements and $10.45 million in fresh funding, but the freight software company is still loss-making and yet to generate meaningful MOSAIC revenue. Management expects initial billings in the December quarter as it works to convert signed customers into live, billable usage.
Sophie Babbage
Sophie Babbage
30 Sept 2026
Quantum Graphite has moved Uley 2 into front-end engineering and design, renewed key mining leases and formalised its downstream structure with Sunlands Pure Group. But the company ended FY2026 with just $210,710 in cash, $10.50 million in borrowings and an auditor-documented material uncertainty over its ability to continue as a going concern.
Maxwell Dee
Maxwell Dee
30 Sept 2026
Radiopharm Theranostics reported a A$56.3 million comprehensive loss for fiscal 2026, with operating cash outflows rising to A$52.8 million and cash falling to A$4.1 million. The company says further funding is required, while auditors flag a material uncertainty over its ability to continue as a going concern.
Victor Sage
Victor Sage
30 Sept 2026
Clarity Pharmaceuticals is approaching pivotal Phase III readouts for its prostate cancer imaging agent, backed by AUD178.3 million in liquid assets. The radiopharmaceutical developer remains deeply loss-making, but expanded manufacturing capacity and early clinical signals are pulling its commercial ambitions into sharper focus.
Victor Sage
Victor Sage
30 Sept 2026
Delorean Corporation’s SA1 Salisbury renewable gas project is more than 85% complete after the company returned to near break-even EBITDA in FY2026. But the annual report carries a material uncertainty over going concern, leaving commissioning, refinancing and new funding as critical tests for the ASX-listed developer.
Victor Sage
Victor Sage
30 Sept 2026
Right Resources posted a A$5.16 million loss for FY2026 and warned of material uncertainty over its ability to continue as a going concern, despite A$3.24 million in cash at year-end and a subsequent A$2.94 million capital raise. The explorer is betting that new drilling at Blue and a revised geological model at Pilot can improve the investment case.
Maxwell Dee
Maxwell Dee
30 Sept 2026
Wildcat Resources has entered FY27 with a $60 million placement, a $37.2 million year-end cash balance and its Tabba Tabba lithium project advancing towards a definitive feasibility study. The funding strengthens the development runway, but final investment approval, financing and approvals remain ahead.
Maxwell Dee
Maxwell Dee
30 Sept 2026
Temas Resources has generated its first revenue from its regenerative chloride leaching technology, but the milestone arrives alongside a wider first-half loss, declining cash and an explicit need for further funding by Q4 2026. The company ended June with C$3.39 million in cash and a C$933,940 estimated flow-through tax liability.
Victor Sage
Victor Sage
30 Sept 2026
Parkway Corporate Limited (ASX:PWN) delivered a sharp revenue increase in FY26 and generated positive operating cash flow, but slipped into a statutory loss and flagged significant uncertainty around its ability to continue as a going concern. Key approvals for its Queensland brine project and a new $2 million mining contract offer commercial progress, while funding remains the central test.
Victor Sage
Victor Sage
30 Sept 2026

Browse the archive

Full archive